AXT's Geographic Diversification Positive but Permits Remain Key Gating Factor

What happened

AXT's revenue base is broadening beyond China as European and Asia-Pacific sales surge, driven by improving InP export approvals, according to a Zacks article. The DeepValue master report had already noted early signs of this in Q1 2026, with Europe and Asia-Pacific contributing $7.2M combined, but North America remained negligible at $0.2M. The new report suggests export friction is easing, yet it lacks hard numbers on Q2/Q3 revenue, inventory, or US permits. The core investment thesis still hinges on converting the Coherent prepayment and Beijing capacity into shippable 6-inch InP wafers, which SEC filings have not yet confirmed. Therefore, while geographic diversification is a positive step, the stock remains a WAIT until formal filings show sustained revenue growth and inventory normalization.

Implication

The geographic expansion reduces reliance on China end-market demand and demonstrates demand outside the US, but export controls still gate shipments from China-based fabs. Europe and Asia-Pacific sales growth is consistent with the base case, but the stock already prices in a significant ramp at $49.9, and the risk-reward is not yet attractive below the $38 entry point. The next catalyst is the Q3 10-Q (due late October) to see if revenue and substrate revenue exceeded $22M and inventory stayed below $95M, as outlined in the master report's upgrade conditions. Investors should also monitor Coherent's capacity commitment and whether US-destined permits are granted, as those are critical for the bull case. Until such evidence emerges, the WAIT rating stands, with an attractive entry at $38 and trim above $65.

Thesis delta

The thesis delta is modestly positive: the reported geographic expansion and improving export approvals suggest the base case is playing out as expected. However, it does not yet upgrade the rating because the article lacks quantitative evidence of US permit progress or sufficient revenue scale to clear the bull-case hurdles. The key differentiator remains whether AXT can convert backlog and the Coherent prepayment into shipped wafers, which requires confirmation in upcoming 10-Q filings.